FINHUB Insights

PODD · Q3 FY25 · Jul 1 – Sep 30, 2025

Insulet Q3 FY25: where the revenue came from and where it went

Insulet Q3 FY25: revenue $0.7B (+30% year over year). Net profit $0.1B. Largest cohort U.S.Omnipod $0.5B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Nov 6, 2025 10-Q
Sankey diagram of Insulet's income statement for Q3 FY25: revenue of $0.7 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.7B +30% year over year
Gross profit$0.5B 72% margin
Operating profit$0.1B 17% margin
Net profit$0.1B 12% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 0.7 100% +30%
U.S.Omnipod 0.5 71% +26%
International Omnipod 0.2 29% +47%
Cost of revenue−0.229%
Gross profit0.572% margin+3pp
Research & development−0.111%+1pp
SG&A−0.345%+2pp
Operating profit0.117% margin+0pp
Net profit0.112%−2pp
Filing on EDGAR More quarters of PODD

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters